Actis Biologics to commence phase-III clinical trial on colon cancer soon
Monday, June 01, 2009 08:00 IST Gireesh Babu, Mumbai
Mumbai-based Actis Biologics Pvt Ltd, the biotech research and technology incubator company, is expecting approval to initiate phase-III studies of its potential anti-sense speciality product, Angiozyme, for colon cancer in India shortly.